At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Apr 8, 2026 at 08:49 ET
Analysis based on filing metadata only, document content was unavailable
- Form DEFA14A is a definitive additional proxy statement
- Filed by the registrant Mineralys Therapeutics, Inc.
- No fee required for filing
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access